Follow on Google News News By Tag * Pathology * Cancer Drug Development * pharma R&D * Tissue Diagnostics * Pharmaceutical Conference * Pathology Conference * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Pathology in Cancer Drug Development among Sessions at CHI’s Tissue-Based Diagnostics ConferencePathology in cancer drug development is one of the sessions taking place at CHI’s inaugural Innovative Tissue-Based Diagnostics: Decoding Cancer & Other Maladies conference being held on June 4-5, 2012 at the Loews Hotel in Philadelphia, PA.
Pathology in Cancer Drug Development Session Schedule: Monday, June 4 (1:30-5:30 pm) 1:30-2:00 Pathology Contributions to Pharma R&D: Enabling Key Intersections between Scientific Discovery and Tissue Diagnostics John Lowe, M.D., Senior Director of Pathology, Genentech 2:00-2:30 Characterization and Clinical Validation of an Immunohistochemical Assay for MET in NSCLC Hartmut Koeppen, M.D., Ph.D., Staff Pathologist, Genentech 2:30-3:00 Chasing the Holy Grail - Towards Pathway Analysis of Circulating Tumor Cells Arndt Schmitz, Ph.D., Senior Scientist, Global Biomarker Research, Bayer Pharma AG 3:00-3:30 Sponsored presentation 3:30-4:00 Refreshment Break with Exhibit & Poster Viewing 4:00-4:30 Nuclear Heat-Shock Factor 1 (HSF1) as a Predictor of Poor Prognosis in Breast Cancer. Tan A. Ince, M.D., Ph.D., Assistant Professor, Pathology; Director, Tumor Stem Cell Division; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine 4:30-5:00 microRNAs as Potential Biomarkers in Cancer Laura J. Tafe, M.D., Assistant Director, Molecular Pathology, Assistant Professor, Department of Pathology, Dartmouth-Hitchcock Medical Center 5:00-5:30 mTOR Pathway in Urologic Malignancies: George Netto, M.D., Associate Professor,Pathology, Urology and Oncology, Johns Hopkins University School of Medicine In the other two sessions, CHI’s speakers will address molecular pathology as the driving force for personalized oncology and bridging radiology-pathology divide. View additional presentations and register at http://www.healthtech.com/ Advance registration discount deadline is April 27, 2012. About Cambridge Healthtech Institute (www.chicorporate.com) CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and eCliniqua. Founded in 1992, CHI strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Contact: James Prudhomme Cambridge Healthtech Institute 781-972-5400 jprudhomme@healthtech.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|